1 Yuan-bin Song, MD, Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation, Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Jing-bo Xu, MD, Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China; Robert Peter Gale, MD, Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation, Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China, Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology & Medicine, London, London, United Kingdom; and Yang Liang, MD, Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation, Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.